604 related articles for article (PubMed ID: 11309628)
1. Cellular immune responses to HIV.
McMichael AJ; Rowland-Jones SL
Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
[TBL] [Abstract][Full Text] [Related]
2. CD8 lymphocytes in HIV infection: helpful and harmful.
Famularo G; Moretti S; Marcellini S; Nucera E; De Simone C
J Clin Lab Immunol; 1997; 49(1):15-32. PubMed ID: 9819670
[TBL] [Abstract][Full Text] [Related]
3. In vitro selection of HIV and CMV specific T-lymphocytes.
Li Pira G; Bottone L; Ivaldi F; Ricciardi A; Barbano G; Manca F
J Biol Regul Homeost Agents; 2004; 18(2):183-6. PubMed ID: 15471225
[TBL] [Abstract][Full Text] [Related]
4. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic analysis of human immunodeficiency virus (HIV) type 1 cell-mediated immune responses after treatment with an HIV-1 immunogen.
Moss RB; Wallace MR; Giermakowska WK; Webb E; Savary J; Chamberlin-Brandt C; Theofan G; Musil R; Richieri SP; Jensen FC; Carlo DJ
J Infect Dis; 1999 Sep; 180(3):641-8. PubMed ID: 10438350
[TBL] [Abstract][Full Text] [Related]
6. Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.
Papasavvas E; Sandberg JK; Rutstein R; Moore EC; Mackiewicz A; Thiel B; Pistilli M; June RR; Jordan KA; Gross R; Maino VC; Nixon DF; Montaner LJ
J Infect Dis; 2003 Sep; 188(6):873-82. PubMed ID: 12964119
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
[TBL] [Abstract][Full Text] [Related]
8. HIV-infected humans, but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells.
Zarling JM; Ledbetter JA; Sias J; Fultz P; Eichberg J; Gjerset G; Moran PA
J Immunol; 1990 Apr; 144(8):2992-8. PubMed ID: 1969880
[TBL] [Abstract][Full Text] [Related]
9. No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients.
Jaye A; Sarge-Njie R; Schim van der Loeff M; Todd J; Alabi A; Sabally S; Corrah T; Whittle H
J Infect Dis; 2004 Feb; 189(3):498-505. PubMed ID: 14745708
[TBL] [Abstract][Full Text] [Related]
10. Profile of T cell immune responses in HIV-infected children from Uganda.
Ssewanyana I; Elrefaei M; Dorsey G; Ruel T; Jones NG; Gasasira A; Kamya M; Nakiwala J; Achan J; Charlebois E; Havlir D; Cao H
J Infect Dis; 2007 Dec; 196(11):1667-70. PubMed ID: 18008251
[TBL] [Abstract][Full Text] [Related]
11. [Virus-induced immune deficiency disease AIDS: direct pathogenic effect of the virus or immunopathology?].
Zinkernagel R
Verh Dtsch Ges Pathol; 1994; 78():166-70. PubMed ID: 7533980
[TBL] [Abstract][Full Text] [Related]
12. Modelling the influence of activation-induced apoptosis of CD4+ and CD8+ T-cells on the immune system response of a HIV-infected patient.
Stan GB; Belmudes F; Fonteneau R; Zeggwagh F; Lefebvre MA; Michelet C; Ernst D
IET Syst Biol; 2008 Mar; 2(2):94-102. PubMed ID: 18397120
[TBL] [Abstract][Full Text] [Related]
13. Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation.
Suy A; Castro P; Nomdedeu M; García F; López A; Fumero E; Gallart T; Lopalco L; Coll O; Gatell JM; Plana M
J Infect Dis; 2007 Oct; 196(8):1191-201. PubMed ID: 17955438
[TBL] [Abstract][Full Text] [Related]
14. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
15. Vaccine-induced T cells control reversion of AIDS virus immune escape mutants.
Fernandez CS; Smith MZ; Batten CJ; De Rose R; Reece JC; Rollman E; Venturi V; Davenport MP; Kent SJ
J Virol; 2007 Apr; 81(8):4137-44. PubMed ID: 17251297
[TBL] [Abstract][Full Text] [Related]
16. HIV/AIDS vaccines: 2007.
Robinson HL
Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
[TBL] [Abstract][Full Text] [Related]
17. The value of preserving HIV-specific immune responses.
Kaufmann DE; Rosenberg ES
J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
[TBL] [Abstract][Full Text] [Related]
19. Memory CD8+ T cells in HIV infection.
McMichael AJ; Ogg G; Wilson J; Callan M; Hambleton S; Appay V; Kelleher T; Rowland-Jones S
Philos Trans R Soc Lond B Biol Sci; 2000 Mar; 355(1395):363-7. PubMed ID: 10794056
[TBL] [Abstract][Full Text] [Related]
20. The dynamics of CD4+ T-cell depletion in HIV disease.
McCune JM
Nature; 2001 Apr; 410(6831):974-9. PubMed ID: 11309627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]